DE69633233D1 - Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus - Google Patents

Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus

Info

Publication number
DE69633233D1
DE69633233D1 DE69633233T DE69633233T DE69633233D1 DE 69633233 D1 DE69633233 D1 DE 69633233D1 DE 69633233 T DE69633233 T DE 69633233T DE 69633233 T DE69633233 T DE 69633233T DE 69633233 D1 DE69633233 D1 DE 69633233D1
Authority
DE
Germany
Prior art keywords
coronavirus
bcv
cattle
infection
bovin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69633233T
Other languages
English (en)
Other versions
DE69633233T2 (de
Inventor
Sanjay Kapil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kansas State University
Original Assignee
Kansas State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kansas State University filed Critical Kansas State University
Publication of DE69633233D1 publication Critical patent/DE69633233D1/de
Application granted granted Critical
Publication of DE69633233T2 publication Critical patent/DE69633233T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE1996633233 1995-06-12 1996-06-07 Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus Expired - Lifetime DE69633233T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48961495A 1995-06-12 1995-06-12
US489614 1995-06-12
PCT/US1996/009979 WO1996041874A1 (en) 1995-06-12 1996-06-07 Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection

Publications (2)

Publication Number Publication Date
DE69633233D1 true DE69633233D1 (de) 2004-09-30
DE69633233T2 DE69633233T2 (de) 2005-08-11

Family

ID=23944554

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1996633233 Expired - Lifetime DE69633233T2 (de) 1995-06-12 1996-06-07 Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus

Country Status (10)

Country Link
US (1) US5916570A (de)
EP (1) EP0833903B1 (de)
AT (1) ATE274579T1 (de)
AU (1) AU705186B2 (de)
CA (1) CA2224309C (de)
DE (1) DE69633233T2 (de)
DK (1) DK0833903T3 (de)
ES (1) ES2224172T3 (de)
PT (1) PT833903E (de)
WO (1) WO1996041874A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100531491B1 (ko) * 1997-03-10 2005-11-28 바이엘 코포레이션 백신으로서 소 호흡 코로나바이러스
WO2001090340A2 (en) 2000-05-21 2001-11-29 University Of North Carolina At Chapel Hill Assembly of large viral genomes and chromosomes from subclones
US6974577B2 (en) * 2001-02-04 2005-12-13 Novartris Ag Inactivated bovine scours vaccines, processes and method of preventing bovine scours
US7906311B2 (en) * 2002-03-20 2011-03-15 Merial Limited Cotton rat lung cells for virus culture
GB0217434D0 (en) * 2002-07-27 2002-09-04 Royal Vetinary College Biological material
US9023366B2 (en) 2003-07-01 2015-05-05 The Royal Veterinary College Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
GB0315323D0 (en) * 2003-07-01 2003-08-06 Royal Veterinary College Vaccine composition
WO2011008958A1 (en) * 2009-07-17 2011-01-20 The Board Of Regents For Oklahoma State University Supralingual vaccines and applicators
US8440203B2 (en) 2009-11-06 2013-05-14 Intervet Inc. Methods of immunizing pregnant heifers at three months of gestation
KR102243374B1 (ko) * 2019-09-30 2021-04-22 대한민국 소 코로나바이러스, 소 로타바이러스 및 소 바이러스성설사병바이러스에 대한 백신 조성물
KR102234525B1 (ko) * 2020-08-28 2021-03-30 안병철 송아지의 점막관련 전염성 질병을 예방 또는 치료하기 위한 혈청의 제조방법, 상기 방법에 의해 제조된 혈청 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839556A (en) * 1969-11-28 1974-10-01 Univ Nebraska Calf diarrhea virus vaccine and processes
US3838004A (en) * 1970-11-17 1974-09-24 Univ Nebraska Calf diarrhea virus vaccine and processes
US3869547A (en) * 1971-11-10 1975-03-04 Univ Nebraska Calf diarrhea virus vaccine and processes
US3914408A (en) * 1973-10-12 1975-10-21 Univ Nebraska Vaccine for neonatal calf diarrhea

Also Published As

Publication number Publication date
ES2224172T3 (es) 2005-03-01
AU705186B2 (en) 1999-05-20
US5916570A (en) 1999-06-29
CA2224309C (en) 2011-01-25
EP0833903A4 (de) 1999-03-24
WO1996041874A1 (en) 1996-12-27
PT833903E (pt) 2004-11-30
ATE274579T1 (de) 2004-09-15
EP0833903B1 (de) 2004-08-25
CA2224309A1 (en) 1996-12-27
DK0833903T3 (da) 2005-01-03
EP0833903A1 (de) 1998-04-08
AU6383296A (en) 1997-01-09
DE69633233T2 (de) 2005-08-11

Similar Documents

Publication Publication Date Title
PT815235E (pt) Vacinas para peste
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
DE69633233D1 (de) Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus
ATE103297T1 (de) Peptid, immunogene zusammensetzung und impfstoff oder medizinische zubereitung, eine methode zur immunisierung eines saeugetieres gegen lhrh und methode zur verbesserung von mea.
BG98522A (en) Peptides including cytotoxic t-lymphocytic response to the virus of hepatite b
Shope Studies on immunity to swine influenza
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
ATE129900T1 (de) Anwendung von il-4 zur steigerung der immunantwort auf immunogene in impfstoffen.
Olitsky et al. COMPARATIVE STUDIES ON VESICULAR STOMATITIS AND FOOT-AND-MOUTH DISEASE.
JP3109886B2 (ja) 経鼻接種用ワクチン
PT1156791E (pt) Bupropiona para tratar doencas virais
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
Grachev Long-term use of oral poliovirus vaccine from Sabin strains in the Soviet Union
JP2003518508A (ja) イヌジステンバーの処置のための方法
RU94031386A (ru) Вакцина сухая культуральная против вирусного энтерита гусей и способ профилактики и лечения вирусного энтерита гусей
DE2437166C3 (de) Arzneimittel gegen interferonsensible, viralbedingte Infektionskrankheiten
Rhodes Immunization Against Polio
Felfe et al. Trends in production of foot-and-mouth disease vaccine.
ES526382A0 (es) Un procedimiento para preparar una vacuna contra la infeccion por el virus de la diarrea virica de los bovinos
RU94038588A (ru) Способ лечения вторичного иммунодефицита (вид)
GERVAIS Acute arterial thrombosis following injury.
SE9704451D0 (sv) New method and compositions for the treatment of autoimmune diseases
DE2437166B2 (de) Arzneimittel gegen interferonsensible, viralbedingte infektionskrankheiten
ATE76302T1 (de) Verwendung von einer immunstimulanten biologisten substanz zur herstellung eines medikaments zur behandlung des menschlichen immunschwaechevirus.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition